Abstract
Purpose Intracerebral hemorrhage is the most severe form of stroke, with a greater than 75% likelihood of death or severe disability, and half of its mortality occurs in the first 24 hours. The grave nature of intracerebral hemorrhage and the high cost of false negatives in its diagnosis are representative of many medical tasks.
Approach Cost-sensitive machine learning has shown promise in various studies as a method of minimizing unwanted results. In this study, 6 machine learning models were trained on 160 computed tomography brain scans both with and without utility matrices based on penalization, an implementation of cost-sensitive learning.
Results The highest-performing model was the support vector machine, which obtained an accuracy of 97.5%, sensitivity of 95% and specificity of 100% without penalization, and an accuracy of 92.5%, sensitivity of 100% and specificity of 85% with penalization, on a dataset of 40 scans. In both cases, the model outperforms a range of previous work using other techniques despite the small size of, and high heterogeneity in, the dataset.
Conclusion Utility matrices demonstrate strong potential for sensitive yet accurate artificial intelligence techniques in medical contexts and workflows where a reduction of false negatives is crucial.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for conducting this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Exemption provided by the IRB of Sri Aurobindo Institute of Medical Sciences (SAIMS)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used in the manuscript are available under a CC0: Public Domain license at https://www.kaggle.com/felipekitamura/head-ct-hemorrhage/.
